| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 26,333,819 | 25,830,834 | 23,434,096 | 21,671,599 |
| Cost of goods sold | 1,874,214 | 1,937,282 | 1,834,967 | 1,991,987 |
| Gross profit | 24,459,605 | 23,893,552 | 21,599,129 | 19,679,612 |
| Selling, general and administrative | 19,877,875 | 21,553,194 | 21,440,610 | 18,993,255 |
| Research and development | 1,029,591 | 1,257,475 | 1,114,138 | 1,359,530 |
| Change in fair value of earnout liabilities | - | 0 | - | -147,000 |
| Depreciation and amortization | 610,899 | 1,114,231 | 1,124,410 | 1,103,854 |
| Total operating expenses | 21,518,365 | 23,924,900 | 23,679,158 | 21,603,639 |
| Operating income (loss) | 2,941,240 | -31,348 | -2,080,029 | -1,924,027 |
| Interest income | - | 0 | 3,672 | - |
| Interest expense | 1,818,105 | 1,791,568 | 1,317,092 | 927,577 |
| Share of losses from equity method investments | -288,642 | -195,482 | -143,608 | -31,448 |
| Gain on disposal of property and equipment | - | 0 | 9,674 | - |
| Total other income (expense) | -2,106,747 | -1,987,050 | -1,447,354 | -959,025 |
| Net income (loss) from continuing operations | 834,493 | - | - | - |
| Net loss from discontinued operations (including asset impairment charge of 26,472,407 in 2025) (note 3) | -31,246,601 | - | - | - |
| Net loss | -30,412,108 | -2,018,398 | -3,527,383 | -2,883,052 |
| Net loss attributable to noncontrolling interest from continuing operations | -955 | - | - | - |
| Less total net loss attributable to noncontrolling interest | -955 | -4,036 | -206 | -25,284 |
| Net loss attributable to sanara medtech shareholders | -30,411,153 | -2,014,362 | -3,527,177 | -2,857,768 |
| Net income (loss) per share of common stock, basic | -3.52 | -0.23 | -0.41 | -0.34 |
| Net income (loss) per share of common stock, diluted | -3.4 | -0.23 | -0.41 | -0.34 |
| Weighted average number of common shares outstanding, basic | 8,646,668 | 8,612,986 | 8,570,104 | 8,517,381 |
| Weighted average number of common shares outstanding, diluted | 8,940,734 | 8,612,986 | 8,570,104 | 8,517,381 |
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)